Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Colorectal Carcinoma: early-phase trial registry
28 of 54 indexed Colorectal Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #261 of 28,707 conditions by registered trial count.
54 US clinical trials · 28 currently recruiting · #261 of 28,707 conditions by registered trial count
Colorectal Carcinoma: 54 US clinical trials tracked, 28 recruiting.
Colorectal Carcinoma is the subject of 54 registered US clinical trials on ClinicalTrials.gov, 28 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 28 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 8 of these trials.
Enrollment posture brief
Registry condition colorectal-carcinoma
OPEN 28 | RECR 52% | LATE 1 | EARLY 28 | RANK #261 | SPON 8
Volume-matched condition peers
Nearest open-share peer: Aortic Stenosis (52% recruiting · 27 trials)
Colorectal Carcinoma lists 28 open slots (52% of 54 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Colorectal Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Colorectal Carcinoma is recruiting above its size-band peers.
28 of 54 indexed trials (51.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Colorectal Carcinoma trials is spread across many organizations.
National Cancer Institute (NCI) accounts for 8 of 54 trials (14.8%). 32 distinct sponsors appear on at least one study for this condition label.
-
Typical Colorectal Carcinoma enrolment sits around 124 participants.
Median target enrolment is 124 among the 54 trials that report a genuine target (sentinel values excluded). 23 of those (42.6%) plan for fewer than 100 participants.
-
Colorectal Carcinoma research is mostly interventional.
47 interventional and 7 observational studies make up this index (87% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
54 total, page 2 of 2
Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer
National Cancer Institute (NCI)
NCT00828984
Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
Jennerex Biotherapeutics
NCT01394939
Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib
University of Alabama at Birmingham
NCT00582660
Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy
M.D. Anderson Cancer Center
NCT05083338
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 19 |
| Phase 2 | 9 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Colorectal Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Colorectal Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Colorectal Carcinoma page
54 registered trials, 28 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 28 Colorectal Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Cancer Institute (NCI) sponsors the most Colorectal Carcinoma trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colorectal Carcinoma condition card totals 54 registered trials; most-linked intervention Biospecimen Collection; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.